OPTISCAN IMAGING LIMITED DISCLOSUREInsider Transactions (Form 3/4/5)

Change of Director's Interest Notice

Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity OPTISCAN IMAGING LIMITED ABN 81 077 771 987 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Camile Farah Date of last notice 15 January 2026 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct and Indirect Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. 1. Phoenix Financial Pty Ltd <Phoenix Super Fund A/C> The Director is a beneficiary of the fund 2. Dr Marie Anne Teresa J Matias The Director’s spouse 3. Camile Farah and Marie Matias <Farah & Matias Family A/C> The Director is a trustee and beneficiary of the trust Date of change 7 September 2026 No. of securities held prior to change Direct 9,000,000 A Options Indirect 1. 875,000 Shares 2. 24,985 Shares 3. 8,235,294 Shares 3. 1,191,962 Performance Rights 3. 6,157,719 B Options For personal use only Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 2 01/01/2011 Class Fully paid ordinary shares (Shares) Unlisted options exercisable at $0.1925 on or before 9 March 2027 (A Options) Unlisted options exercisable at $0.15 on or before 13 January 2030 (B Options) Performance Rights Number acquired Nil Number disposed Nil Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation Performance Rights and Options were issued as